IL84261A - Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor - Google Patents

Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor

Info

Publication number
IL84261A
IL84261A IL84261A IL8426187A IL84261A IL 84261 A IL84261 A IL 84261A IL 84261 A IL84261 A IL 84261A IL 8426187 A IL8426187 A IL 8426187A IL 84261 A IL84261 A IL 84261A
Authority
IL
Israel
Prior art keywords
thromboxane
diphenyl
pharmaceutical compositions
synthetase inhibitor
dioxane derivative
Prior art date
Application number
IL84261A
Other languages
English (en)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of IL84261A publication Critical patent/IL84261A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL84261A 1986-11-04 1987-10-23 Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor IL84261A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868626297A GB8626297D0 (en) 1986-11-04 1986-11-04 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL84261A true IL84261A (en) 1991-12-15

Family

ID=10606757

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84261A IL84261A (en) 1986-11-04 1987-10-23 Pharmaceutical compositions comprising a 2,4-diphenyl 1,3-dioxane derivative and a thromboxane a2 synthetase inhibitor

Country Status (13)

Country Link
US (1) US4908380A (fr)
EP (1) EP0266980B1 (fr)
JP (1) JPS63130532A (fr)
AT (1) ATE81774T1 (fr)
AU (1) AU608546B2 (fr)
CA (1) CA1308660C (fr)
DE (1) DE3782396T2 (fr)
DK (1) DK576887A (fr)
ES (1) ES2052581T3 (fr)
GB (1) GB8626297D0 (fr)
GR (1) GR3006099T3 (fr)
IL (1) IL84261A (fr)
ZA (1) ZA877886B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
US20110178112A1 (en) 2006-01-18 2011-07-21 Evolva Sa PPAR Modulators
EP2150111B1 (fr) 2007-01-18 2016-10-19 Evolva SA 1,3-dioxanes substitués utilisés en tant que modulateurs ppar
MX2009007667A (es) * 2007-01-18 2011-12-08 Evolva Sa Profarmacos de 1,3-dioxanos sustituidos y sus usos.
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2111050B (en) * 1981-11-19 1985-09-11 Ciba Geigy Ag N-substituted-2-pyridylindoles
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
GB8619450D0 (en) * 1986-08-08 1986-09-17 Glaxo Group Ltd Chemical compositions

Also Published As

Publication number Publication date
CA1308660C (fr) 1992-10-13
DE3782396T2 (de) 1993-07-08
EP0266980A2 (fr) 1988-05-11
EP0266980B1 (fr) 1992-10-28
ZA877886B (en) 1988-05-04
DK576887D0 (da) 1987-11-03
ATE81774T1 (de) 1992-11-15
US4908380A (en) 1990-03-13
GB8626297D0 (en) 1986-12-03
GR3006099T3 (fr) 1993-06-21
ES2052581T3 (es) 1994-07-16
AU608546B2 (en) 1991-04-11
AU8069887A (en) 1988-05-05
DE3782396D1 (de) 1992-12-03
EP0266980A3 (en) 1989-11-08
DK576887A (da) 1988-05-05
JPS63130532A (ja) 1988-06-02

Similar Documents

Publication Publication Date Title
IL110031A0 (en) Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them
LU91145I9 (fr)
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
ATE65397T1 (de) Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.
NO913684L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
SE8404065D0 (sv) Novel biologically active compounds
SE8505488D0 (sv) Isosilybinfri silibinin
HUT51298A (en) Process for producing retarde hirudine derivatives and pharmaceutical compositions containing them as active components
AU696532B2 (en) Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
DE3766695D1 (de) Bizyklische diphosphonat-verbindungen und arzneimittel.
GB8626297D0 (en) Pharmaceutical compositions
NO913683L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
IL85425A (en) Anticonvulsant compositions containing substituted benzoyl anilides, some such novel compounds and process for their preparation
EP0266979A3 (fr) Agents thérapeutiques
NO913685D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
IL97698A0 (en) Hydroxymethyl-indolizidines,quinolizidines and pharmaceutical compositions containing same
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
IT8521895V0 (it) Confezione combinata per laproduzione di masse dentarie.
JO1711B1 (en) Therapeutic agents
SE9304065D0 (sv) New compound
SU1086720A1 (ru) 1,1,1-трихлор-2-окси-4-(4-нитрофенил)бутанон-4 в качестве промежуточного продукта в синтезе 1,1,1-трихлор-4-(4-нитрофенил)бутен-2-она-4 и 1,1,1-трихлор-4-(4-нитрофенил)бутен-2-он-4 в качестве фунгицида

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees